Discovery of a novel Fam20C inhibitor for treatment of triple-negative breast cancer ( vol 286, 138398, 2024)

被引：0
|
作者：
Lu, Yingying [1 ]
Zhen, Yongqi [1 ,2 ,3 ]
Li, Zhijia [1 ]
Luo, Boqin [1 ]
Yin, Bo [1 ]
Zhang, Lan [1 ]
机构：
[1] Southwest Jiaotong Univ, Sichuan Engn Res Ctr Biomimet Synth Nat Drugs, Sch Life Sci & Engn, Chengdu 610031, Peoples R China
[2] Sichuan Univ, West China Hosp, Canc Ctr, Dept Biotherapy, Chengdu 610041, Peoples R China
[3] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu 610041, Peoples R China
来源：
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES | 2025年 / 306卷
关键词：
D O I：
10.1016/j.ijbiomac.2025.141303
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Discovery of a novel Fam20C inhibitor for treatment of triple-negative breast cancer
    Lu, Yingying
    Zhen, Yongqi
    Li, Zhijia
    Luo, Boqin
    Yin, Bo
    Zhang, Lan
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2025, 286
  • [2] Discovery of a novel small-molecule inhibitor of Fam20C that induces apoptosis and inhibits migration in triple negative breast cancer
    Zhao, Rongyan
    Fu, Leilei
    Yuan, Zhaoxin
    Liu, Yi
    Zhang, Kai
    Chen, Yanmei
    Wang, Leiming
    Sun, Dejuan
    Chen, Lixia
    Liu, Bo
    Zhang, Lan
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 210
  • [3] Systematic network-based discovery of a Fam20C inhibitor (FL-1607) with apoptosis modulation in triple-negative breast cancer
    Qin, Ziyi
    Wang, Peiqi
    Li, Xinyi
    Zhang, Shouyue
    Tian, Mao
    Dai, Yi
    Fu, Leilei
    MOLECULAR BIOSYSTEMS, 2016, 12 (07) : 2108 - 2118
  • [4] Discovery of a small molecule inhibitor for triple-negative breast cancer (TNBC)
    Saran, Uttara
    Chandrasekaran, Balaji
    Tyagi, Ashish
    Singh, Amandeep
    Ankem, Murali K.
    Sharma, Arun K.
    Damodaran, Chendil
    CANCER RESEARCH, 2022, 82 (12)
  • [5] Novel Treatment Approaches for Triple-Negative Breast Cancer
    Telli, Melinda L.
    Ford, James M.
    CLINICAL BREAST CANCER, 2010, 10 : E16 - E22
  • [6] Bazedoxifene as a novel GP130 inhibitor for the treatment of triple-negative breast cancer
    Tian, Jilai
    Cao, Yang
    Chen, Xiang
    Xiao, Hui
    Li, Chenglong
    Lin, Jiayuh
    CANCER RESEARCH, 2017, 77
  • [7] Small-molecule inhibitor of Fam20C in combination with paclitaxel suppresses tumor growth by LIF-JAK2/STAT3-modulated apoptosis in triple-negative breast cancer
    Yuan, Zhaoxin
    Zhen, Yongqi
    Chen, Siwei
    Li, Zixiang
    Fu, Leilei
    JOURNAL OF THE TAIWAN INSTITUTE OF CHEMICAL ENGINEERS, 2023, 143
  • [8] Recent Advances in Drug Discovery for Triple-Negative Breast Cancer Treatment
    Masci, Domiziana
    Naro, Chiara
    Puxeddu, Michela
    Urbani, Andrea
    Sette, Claudio
    La Regina, Giuseppe
    Silvestri, Romano
    MOLECULES, 2023, 28 (22):
  • [9] Development of a RSK Inhibitor as a Novel Therapy for Triple-Negative Breast Cancer
    Ludwik, Katarzyna A.
    Campbell, J. Preston
    Li, Mingzong
    Li, Yu
    Sandusky, Zachary M.
    Pasic, Lejla
    Sowder, Miranda E.
    Brenin, David R.
    Pietenpol, Jennifer A.
    O'Doherty, George A.
    Lannigan, Deborah A.
    MOLECULAR CANCER THERAPEUTICS, 2016, 15 (11) : 2598 - 2608
  • [10] Novel immune targets for the treatment of triple-negative breast cancer
    Corti, Chiara
    Nicolo, Eleonora
    Curigliano, Giuseppe
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2021, 25 (10) : 815 - 834
12345